GlassScriptPhysician profile
Philomena E Ukwade
NPI 1972593358
$2,887.09
in general payments reported to CMS, 2019-2025
29 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2020: $445 · 2021: $439 · 2022: $460 · 2023: $431 · 2024: $376 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $952.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $653.94 | 2019-2025 | Farxiga |
| Lilly USA, LLC | $534.11 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $284.03 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $207.74 | 2019-2024 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.46 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $137.05 | 2019-2021 | |
| Pfizer INC. | $132.42 | 2020-2024 | |
| Janssen Pharmaceuticals, INC | $121.07 | 2019-2025 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $67.85 | 2022-2023 | |
| Exact Sciences Corporation | $58.84 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $49.31 | 2022-2023 | Freestyle Libre 3 |
| Renalytix Ai, INC. | $46.44 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Genentech USA, INC. | $44.67 | 2019-2020 | |
| Amarin Pharma, INC. | $41.76 | 2019-2020 | |
| Hologic Sales and Service, LLC | $39.02 | 2024 | Aptima, Thinprep 2000 Processor |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $37.74 | 2019-2020 | |
| Eisai INC. | $35.33 | 2021-2022 | |
| Edwards Lifesciences Corporation | $28.96 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Nevro Corp. | $26.87 | 2020 | |
| Alexion Pharmaceuticals, INC. | $22.91 | 2021 | |
| Glaxosmithkline, LLC. | $21.51 | 2024 | Trelegy Ellipta |
| Seqirus USA INC | $20.59 | 2025 | Flucelvax, Fluad |
| Inspire Medical Systems, INC. | $17.71 | 2024 | Inspire |
| Kowa Pharmaceuticals America, INC. | $13.71 | 2021 | |
| Esperion Therapeutics, INC. | $13.22 | 2024 | Nexletol |
| Arbor Pharmaceuticals, INC. | $13.22 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.79 | 2021 | |
| Allergan, INC. | $10.82 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philomena Ukwade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.